Cargando…
Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy
X-linked myotubular myopathy (XLMTM, also known as XLCNM) is a severe congenital muscular disorder due to mutations in the myotubularin gene, MTM1. It is characterized by generalized hypotonia, leading to neonatal death of most patients. No specific treatment exists. Here, we show that tamoxifen, a...
Autores principales: | Gayi, Elinam, Neff, Laurence A., Massana Muñoz, Xènia, Ismail, Hesham M., Sierra, Marta, Mercier, Thomas, Décosterd, Laurent A., Laporte, Jocelyn, Cowling, Belinda S., Dorchies, Olivier M., Scapozza, Leonardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243013/ https://www.ncbi.nlm.nih.gov/pubmed/30451843 http://dx.doi.org/10.1038/s41467-018-07058-4 |
Ejemplares similares
-
Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
por: Gómez-Oca, Raquel, et al.
Publicado: (2021) -
Centronuclear (myotubular) myopathy
por: Jungbluth, Heinz, et al.
Publicado: (2008) -
Tamoxifen therapy in a murine model of myotubular myopathy
por: Maani, Nika, et al.
Publicado: (2018) -
Inactivating the lipid kinase activity of PI3KC2β is sufficient to rescue myotubular myopathy in mice
por: Massana-Muñoz, Xènia, et al.
Publicado: (2023) -
Natural history study and statistical modeling of disease progression in a preclinical model of myotubular myopathy
por: Buono, Suzie, et al.
Publicado: (2022)